In a major breakthrough for the life sciences sector, MIT spinout Cache DNA is transforming biomolecule storage—without the need for freezing. The company has pioneered cutting-edge technologies that allow DNA, and potentially other vital biomolecules, to be preserved safely at room temperature. By eliminating the reliance on bulky freezers and complex cold chain logistics, this innovation could significantly impact global healthcare and advance the field of precision medicine.
During the Covid-19 pandemic, it became evident that the reliance on cold storage had costly downfall. Vaccines lost their chill and, by extension, their viability, resulting in waste and a critical setback in vaccination efforts. To put it simply, power outages, delays, and equipment failures all pose serious threats to perishable medical samples, noted by MIT News. In more remote and developing regions, the lack of robust refrigeration technologies can stand as a formidable barrier to accessing groundbreaking treatments—think CAR-T cell therapies and personalized cancer treatments.
Jettisoning the industry from the freezer's grip is the battle cry for Cache DNA co-founders James Banal, a former MIT postdoc, and MIT Professor Mark Bathe. They have married their scientific prowess to forge a method that keeps DNA intact without the deep freeze. "We want to challenge the paradigm," Banal told MIT News. Pointedly, he highlighted the irony of advancements in DNA sequencing becoming more affordable and accessible, yet the storage and transportation remain in a technological time warp.
It's not just about the DNA, however. The broad-reaching implications touch on every aspect of healthcare logistics, from simple blood tests to pandemic preparedness. Bathe summed up the vision: "Eliminating the cold chain is half the equation." He envisions a future where a global repository of nucleic acids can be maintained and accessed as easily and inexpensively as retrieving books from a massive digital library. Samples that might have been discarded due to limited storage capacity could now be preserved indefinitely. In the hands of researchers in places like Florida and Singapore, this means reduced degradation from humidity and the ability to collect more comprehensive data beyond the confines of traditional laboratories, in a statement obtained by MIT News.
The development of this freezer-free preservation system is grounded in scientific collaboration between Banal, Bathe, and chemistry professor Jeremiah Johnson, who introduced amber-like polymers partially inspired by concepts from "Jurassic Park," according to MIT News. These polymers, when heated, solidify around DNA to form a protective barrier that resists water and enzymes known to degrade genetic material. As Cache DNA continues to advance this technology, it presents potential for broader access to genetic research and sample preservation, particularly in regions where reliable electricity is limited.
The benefits of the technology are already becoming evident: last year, Cache DNA distributed over a hundred alpha DNA preservation kits to researchers around the globe, leading to a range of promising and varied applications. “Hospitals told us they were running out of space,” Banal noted in an interview with MIT News. This technology opens up new possibilities for island nations to study their unique genetic makeup and for patients with rare diseases to contribute valuable data to research without relying on large, centralized healthcare facilities.
